IFM Therapeutics, a Boston based biopharmaceutical company, announced it has closed on $55.5 million in financing. The financing was led by Omega Funds, which participation...
Biological, medical and environmental science related startups.
Werewolf Therapeutics announced it has raised $56 million in Series A funding to advance its pipeline of next-generation, transformative cancer treatments. The oncology biotherapeutics company...
The new platform raised new funding for its solutions for treating rare muscle disorders.
The $100 million Series B round was led by Fresenius Medical Care Ventures.
The new funding funding is for its new cell therapies for cancer patients.
Merck and Bristol-Myers Squibb both provided strategic investments in latest round.
Startup gets additional funding from partnerships, bringing total to $15 million.
The new funding will help the startup develop new oncology programs.
TruTag announced it raised new funding for its product identification platform